Intended for healthcare professionals

Analysis

Pregabalin: what the patent litigation means for doctors and drug companies

BMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k2318 (Published 07 June 2018) Cite this as: BMJ 2018;361:k2318